Nissen, Steven ESteven ENissenYeomans, Neville DNeville DYeomansSolomon, Daniel HDaniel HSolomonLüscher, Thomas FThomas FLüscherLibby, PeterPeterLibbyHusni, M ElaineM ElaineHusniGraham, David YDavid YGrahamBorer, Jeffrey SJeffrey SBorerWisniewski, Lisa MLisa MWisniewskiWolski, Katherine EKatherine EWolskiWang, QiuqingQiuqingWangMenon, VenuVenuMenonRuschitzka, FrankFrankRuschitzkaGaffney, MichaelMichaelGaffneyBeckerman, BruceBruceBeckermanBerger, Manuela FManuela FBergerBao, WeihangWeihangBaoLincoff, A MichaelA MichaelLincoffPING-NING HSU2023-09-282023-09-282016-12-2900284793https://pubmed.ncbi.nlm.nih.gov/27959716/https://scholars.lib.ntu.edu.tw/handle/123456789/635863The cardiovascular safety of celecoxib, as compared with nonselective nonsteroidal antiinflammatory drugs (NSAIDs), remains uncertain.en[SDGs]SDG3Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritisjournal article10.1056/NEJMoa1611593279597162-s2.0-85007368852https://api.elsevier.com/content/abstract/scopus_id/85007368852